- Home
- SILO vs ABVC Comparison
SILO vs ABVC Comparison
Compare SILO & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- ABVC
- Stock Information
- Founded
- SILO 2010
- ABVC 2015
- Country
- SILO United States
- ABVC United States
- Employees
- SILO N/A
- ABVC N/A
- Industry
- SILO Apparel
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- SILO Consumer Discretionary
- ABVC Health Care
- Exchange
- SILO Nasdaq
- ABVC Nasdaq
- Market Cap
- SILO 8.8M
- ABVC 9.9M
- IPO Year
- SILO N/A
- ABVC N/A
- Fundamental
- Price
- SILO $1.35
- ABVC $0.70
- Analyst Decision
- SILO
- ABVC
- Analyst Count
- SILO 0
- ABVC 0
- Target Price
- SILO N/A
- ABVC N/A
- AVG Volume (30 Days)
- SILO 228.4K
- ABVC 1.2M
- Earning Date
- SILO 03-04-2025
- ABVC 03-12-2025
- Dividend Yield
- SILO N/A
- ABVC N/A
- EPS Growth
- SILO N/A
- ABVC N/A
- EPS
- SILO N/A
- ABVC N/A
- Revenue
- SILO $72,102.00
- ABVC $509,788.00
- Revenue This Year
- SILO $1.86
- ABVC N/A
- Revenue Next Year
- SILO N/A
- ABVC N/A
- P/E Ratio
- SILO N/A
- ABVC N/A
- Revenue Growth
- SILO N/A
- ABVC N/A
- 52 Week Low
- SILO $0.77
- ABVC $0.40
- 52 Week High
- SILO $4.50
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- SILO 40.14
- ABVC 75.66
- Support Level
- SILO $1.39
- ABVC $0.40
- Resistance Level
- SILO $1.52
- ABVC $0.88
- Average True Range (ATR)
- SILO 0.14
- ABVC 0.08
- MACD
- SILO -0.05
- ABVC 0.02
- Stochastic Oscillator
- SILO 0.97
- ABVC 62.42
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.